BRENNA BROWN: Open Payments
NPI 1689268047 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,369 in 104 payments from 25 companies in 2025. Trend: 2023 $68 · 2024 $894 · 2025 $2,369
Food & beverage: $2,369
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $342 |
| Lilly USA, LLC | 10 | $263 |
| Corcept Therapeutics | 14 | $241 |
| Neurocrine BioSciences, Inc. | 8 | $204 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $158 |
| Dexcom, Inc. | 7 | $155 |
| BETA BIONICS, INC. | 4 | $137 |
| Ascendis Pharma Endocrinology Inc | 5 | $127 |
| Insulet Corporation | 2 | $94 |
| Xeris Pharmaceuticals, Inc. | 4 | $80 |
Products named: Ozempic, Korlym, CRENESSITY, Kerendia, Dexcom G6 Transmitter, JARDIANCE, iLet Bionic Pancreas, Yorvipath.
Industry payments across TX — which companies pay providers there.
